Dermatology CRO - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB512244107

Publication Date:

December 3, 2024

Pages:

126

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

A dermatology CRO is a CRO dedicated to research addressing dermatological diseases, and a contract research organization is an organization that supports a pharmaceutical or biotechnology company in conducting outsourced research services.
The global market for Dermatology CRO was estimated to be worth US$ 75 million in 2023 and is forecast to a readjusted size of US$ 128.1 million by 2030 with a CAGR of 6.8% during the forecast period 2024-2030
A dermatology CRO is a CRO dedicated to research addressing dermatological diseases, and a contract research organization is an organization that supports a pharmaceutical or biotechnology company in conducting outsourced research services.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Dermatology CRO, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Dermatology CRO by region & country, by Type, and by Application.
The Dermatology CRO market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dermatology CRO.
麻豆原创 Segmentation
By Company
IQVIA
Covance
Thermo Fisher Scientific
Parexel International Corporation
Charles River Laboratories International
Icon
Medidata Solutions
Syneos Health
Pharmaron
GVK Biosciences Private Limited
Wuxi AppTec
MEDPACE HOLDINGS
ICON
CTI Clinical Trial & Consulting
Bioskin
Proinnovera
Biorasi
Javara
TFS HealthScience
Segment by Type:
Discover Drug Services
Clinical Services
Preclinical Services
Segment by Application
Laboratory
Medical Writing
Clinical Monitoring
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Dermatology CRO manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Dermatology CRO in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Dermatology CRO in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Dermatology CRO Product Introduction
1.2 Global Dermatology CRO 麻豆原创 Size Forecast
1.3 Dermatology CRO 麻豆原创 Trends & Drivers
1.3.1 Dermatology CRO Industry Trends
1.3.2 Dermatology CRO 麻豆原创 Drivers & Opportunity
1.3.3 Dermatology CRO 麻豆原创 Challenges
1.3.4 Dermatology CRO 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Dermatology CRO Players Revenue Ranking (2023)
2.2 Global Dermatology CRO Revenue by Company (2019-2024)
2.3 Key Companies Dermatology CRO Manufacturing Base Distribution and Headquarters
2.4 Key Companies Dermatology CRO Product Offered
2.5 Key Companies Time to Begin Mass Production of Dermatology CRO
2.6 Dermatology CRO 麻豆原创 Competitive Analysis
2.6.1 Dermatology CRO 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Dermatology CRO Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermatology CRO as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Discover Drug Services
3.1.2 Clinical Services
3.1.3 Preclinical Services
3.2 Global Dermatology CRO Sales Value by Type
3.2.1 Global Dermatology CRO Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Dermatology CRO Sales Value, by Type (2019-2030)
3.2.3 Global Dermatology CRO Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Laboratory
4.1.2 Medical Writing
4.1.3 Clinical Monitoring
4.1.4 Others
4.2 Global Dermatology CRO Sales Value by Application
4.2.1 Global Dermatology CRO Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Dermatology CRO Sales Value, by Application (2019-2030)
4.2.3 Global Dermatology CRO Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Dermatology CRO Sales Value by Region
5.1.1 Global Dermatology CRO Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Dermatology CRO Sales Value by Region (2019-2024)
5.1.3 Global Dermatology CRO Sales Value by Region (2025-2030)
5.1.4 Global Dermatology CRO Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Dermatology CRO Sales Value, 2019-2030
5.2.2 North America Dermatology CRO Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Dermatology CRO Sales Value, 2019-2030
5.3.2 Europe Dermatology CRO Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Dermatology CRO Sales Value, 2019-2030
5.4.2 Asia Pacific Dermatology CRO Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Dermatology CRO Sales Value, 2019-2030
5.5.2 South America Dermatology CRO Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Dermatology CRO Sales Value, 2019-2030
5.6.2 Middle East & Africa Dermatology CRO Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Dermatology CRO Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Dermatology CRO Sales Value
6.3 United States
6.3.1 United States Dermatology CRO Sales Value, 2019-2030
6.3.2 United States Dermatology CRO Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Dermatology CRO Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Dermatology CRO Sales Value, 2019-2030
6.4.2 Europe Dermatology CRO Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Dermatology CRO Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Dermatology CRO Sales Value, 2019-2030
6.5.2 China Dermatology CRO Sales Value by Type (%), 2023 VS 2030
6.5.3 China Dermatology CRO Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Dermatology CRO Sales Value, 2019-2030
6.6.2 Japan Dermatology CRO Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Dermatology CRO Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Dermatology CRO Sales Value, 2019-2030
6.7.2 South Korea Dermatology CRO Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Dermatology CRO Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Dermatology CRO Sales Value, 2019-2030
6.8.2 Southeast Asia Dermatology CRO Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Dermatology CRO Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Dermatology CRO Sales Value, 2019-2030
6.9.2 India Dermatology CRO Sales Value by Type (%), 2023 VS 2030
6.9.3 India Dermatology CRO Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 IQVIA
7.1.1 IQVIA Profile
7.1.2 IQVIA Main Business
7.1.3 IQVIA Dermatology CRO Products, Services and Solutions
7.1.4 IQVIA Dermatology CRO Revenue (US$ Million) & (2019-2024)
7.1.5 IQVIA Recent Developments
7.2 Covance
7.2.1 Covance Profile
7.2.2 Covance Main Business
7.2.3 Covance Dermatology CRO Products, Services and Solutions
7.2.4 Covance Dermatology CRO Revenue (US$ Million) & (2019-2024)
7.2.5 Covance Recent Developments
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Profile
7.3.2 Thermo Fisher Scientific Main Business
7.3.3 Thermo Fisher Scientific Dermatology CRO Products, Services and Solutions
7.3.4 Thermo Fisher Scientific Dermatology CRO Revenue (US$ Million) & (2019-2024)
7.3.5 Parexel International Corporation Recent Developments
7.4 Parexel International Corporation
7.4.1 Parexel International Corporation Profile
7.4.2 Parexel International Corporation Main Business
7.4.3 Parexel International Corporation Dermatology CRO Products, Services and Solutions
7.4.4 Parexel International Corporation Dermatology CRO Revenue (US$ Million) & (2019-2024)
7.4.5 Parexel International Corporation Recent Developments
7.5 Charles River Laboratories International
7.5.1 Charles River Laboratories International Profile
7.5.2 Charles River Laboratories International Main Business
7.5.3 Charles River Laboratories International Dermatology CRO Products, Services and Solutions
7.5.4 Charles River Laboratories International Dermatology CRO Revenue (US$ Million) & (2019-2024)
7.5.5 Charles River Laboratories International Recent Developments
7.6 Icon
7.6.1 Icon Profile
7.6.2 Icon Main Business
7.6.3 Icon Dermatology CRO Products, Services and Solutions
7.6.4 Icon Dermatology CRO Revenue (US$ Million) & (2019-2024)
7.6.5 Icon Recent Developments
7.7 Medidata Solutions
7.7.1 Medidata Solutions Profile
7.7.2 Medidata Solutions Main Business
7.7.3 Medidata Solutions Dermatology CRO Products, Services and Solutions
7.7.4 Medidata Solutions Dermatology CRO Revenue (US$ Million) & (2019-2024)
7.7.5 Medidata Solutions Recent Developments
7.8 Syneos Health
7.8.1 Syneos Health Profile
7.8.2 Syneos Health Main Business
7.8.3 Syneos Health Dermatology CRO Products, Services and Solutions
7.8.4 Syneos Health Dermatology CRO Revenue (US$ Million) & (2019-2024)
7.8.5 Syneos Health Recent Developments
7.9 Pharmaron
7.9.1 Pharmaron Profile
7.9.2 Pharmaron Main Business
7.9.3 Pharmaron Dermatology CRO Products, Services and Solutions
7.9.4 Pharmaron Dermatology CRO Revenue (US$ Million) & (2019-2024)
7.9.5 Pharmaron Recent Developments
7.10 GVK Biosciences Private Limited
7.10.1 GVK Biosciences Private Limited Profile
7.10.2 GVK Biosciences Private Limited Main Business
7.10.3 GVK Biosciences Private Limited Dermatology CRO Products, Services and Solutions
7.10.4 GVK Biosciences Private Limited Dermatology CRO Revenue (US$ Million) & (2019-2024)
7.10.5 GVK Biosciences Private Limited Recent Developments
7.11 Wuxi AppTec
7.11.1 Wuxi AppTec Profile
7.11.2 Wuxi AppTec Main Business
7.11.3 Wuxi AppTec Dermatology CRO Products, Services and Solutions
7.11.4 Wuxi AppTec Dermatology CRO Revenue (US$ Million) & (2019-2024)
7.11.5 Wuxi AppTec Recent Developments
7.12 MEDPACE HOLDINGS
7.12.1 MEDPACE HOLDINGS Profile
7.12.2 MEDPACE HOLDINGS Main Business
7.12.3 MEDPACE HOLDINGS Dermatology CRO Products, Services and Solutions
7.12.4 MEDPACE HOLDINGS Dermatology CRO Revenue (US$ Million) & (2019-2024)
7.12.5 MEDPACE HOLDINGS Recent Developments
7.13 ICON
7.13.1 ICON Profile
7.13.2 ICON Main Business
7.13.3 ICON Dermatology CRO Products, Services and Solutions
7.13.4 ICON Dermatology CRO Revenue (US$ Million) & (2019-2024)
7.13.5 ICON Recent Developments
7.14 CTI Clinical Trial & Consulting
7.14.1 CTI Clinical Trial & Consulting Profile
7.14.2 CTI Clinical Trial & Consulting Main Business
7.14.3 CTI Clinical Trial & Consulting Dermatology CRO Products, Services and Solutions
7.14.4 CTI Clinical Trial & Consulting Dermatology CRO Revenue (US$ Million) & (2019-2024)
7.14.5 CTI Clinical Trial & Consulting Recent Developments
7.15 Bioskin
7.15.1 Bioskin Profile
7.15.2 Bioskin Main Business
7.15.3 Bioskin Dermatology CRO Products, Services and Solutions
7.15.4 Bioskin Dermatology CRO Revenue (US$ Million) & (2019-2024)
7.15.5 Bioskin Recent Developments
7.16 Proinnovera
7.16.1 Proinnovera Profile
7.16.2 Proinnovera Main Business
7.16.3 Proinnovera Dermatology CRO Products, Services and Solutions
7.16.4 Proinnovera Dermatology CRO Revenue (US$ Million) & (2019-2024)
7.16.5 Proinnovera Recent Developments
7.17 Biorasi
7.17.1 Biorasi Profile
7.17.2 Biorasi Main Business
7.17.3 Biorasi Dermatology CRO Products, Services and Solutions
7.17.4 Biorasi Dermatology CRO Revenue (US$ Million) & (2019-2024)
7.17.5 Biorasi Recent Developments
7.18 Javara
7.18.1 Javara Profile
7.18.2 Javara Main Business
7.18.3 Javara Dermatology CRO Products, Services and Solutions
7.18.4 Javara Dermatology CRO Revenue (US$ Million) & (2019-2024)
7.18.5 Javara Recent Developments
7.19 TFS HealthScience
7.19.1 TFS HealthScience Profile
7.19.2 TFS HealthScience Main Business
7.19.3 TFS HealthScience Dermatology CRO Products, Services and Solutions
7.19.4 TFS HealthScience Dermatology CRO Revenue (US$ Million) & (2019-2024)
7.19.5 TFS HealthScience Recent Developments
8 Industry Chain Analysis
8.1 Dermatology CRO Industrial Chain
8.2 Dermatology CRO Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Dermatology CRO Sales Model
8.5.2 Sales Channel
8.5.3 Dermatology CRO Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

IQVIA
Covance
Thermo Fisher Scientific
Parexel International Corporation
Charles River Laboratories International
Icon
Medidata Solutions
Syneos Health
Pharmaron
GVK Biosciences Private Limited
Wuxi AppTec
MEDPACE HOLDINGS
ICON
CTI Clinical Trial & Consulting
Bioskin
Proinnovera
Biorasi
Javara
TFS HealthScience

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.